Cite
HARVARD Citation
Wheeler, C. et al. (n.d.). Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet infectious diseases. 16 (10), pp. 1154-1168. [Online].